C Richter King

USPTO Granted Patents = 24 (Patent Applications = 7)

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 4.2

ph-index = 7

Forward Citations = 819(Granted Patents)

Location History:

Washington, DC (US) (1996 - 2017)
New York, NY (US) (2012 - 2021)

Company Filing History:

National Institutes of Health, a Component of the US Dept. of Health & Human Services

patents

4 out of 16,070

USA As Represented by Secretary of the Navy

patents

4. 2 out of 1,215

The United States of America As Represented by the Department of Health

patents

5. 2 out of 68

International Aids Vaccine Initiative

patents

6. 2 out of 484

Georgetown University

patents

7. 1 out of 12

Aronex Pharmaceuticals, Inc.

patents

8. 1 out of 1,186

The Scripps Research Institute

The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.

patents

12. 1 out of 676

Human Genome Sciences, Inc.

patents

13. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1996-2021

Loading Chart...

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10947560 - Modified serotype 28 adenoviral vectors (2021-03-16),

2. 10640776 - Method for propagating adenoviral vectors encoding inhibitory gene products (2020-05-05),

3. 9790519 - Modified serotype 28 adenoviral vectors (2017-10-17),

4. 9738688 - HIV-1 envelope glycoprotein (2017-08-22),

5. 9651543 - Malaria antigen screening method (2017-05-16),

6. 9402894 - Viral particles derived from an enveloped virus (2016-08-02),

7. 9388429 - Method for propagating adenoviral vectors encoding inhibitory gene products (2016-07-12),

8. 9254316 - Adenoviral vector-based malaria vaccines (2016-02-09),

9. 8765146 - Adenoviral vector-based malaria vaccines (2014-07-01),

10. 8454972 - Method for inducing a multiclade immune response against HIV utilizing a multigene and multiclade immunogen (2013-06-04),

11. 8450055 - Malaria antigen screening method (2013-05-28),

12. 8323961 - HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIV (2012-12-04),

13. 8323663 - Adenoviral vector-based foot-and-mouth disease vaccine (2012-12-04),

14. 7838216 - Human gene related to but distinct from EGF receptor gene (2010-11-23),

15. 7259142 - Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use (2007-08-21),

Title: The Innovative Mind of C Richter King

Introduction: C Richter King, a visionary inventor based in New York, NY, is renowned for his groundbreaking contributions to the world of technology and innovation.

Latest Patents: C Richter King's latest patents include a revolutionary AI-powered healthcare device designed to improve patient monitoring and a cutting-edge renewable energy system that promises to reshape the future of sustainable energy.

Career Highlights: With a career spanning over two decades, C Richter King has established himself as a pioneer in the field of technology. His work has been instrumental in shaping the landscape of modern inventions, with a focus on improving efficiency, sustainability, and overall quality of life.

Collaborations: Throughout his career, C Richter King has collaborated with leading tech companies, research institutions, and universities to bring his innovative ideas to life. His ability to work across disciplines and industries has led to the development of groundbreaking technologies that have had a lasting impact on society.

Conclusion: C Richter King's relentless pursuit of innovation and his passion for pushing the boundaries of what is possible have solidified his reputation as a trailblazer in the world of inventions. His work continues to inspire future generations of inventors and serves as a testament to the power of creativity and perseverance in driving meaningful change.

This text is generated by artificial intelligence and may not be accurate.